Mclean Hospital: Psychotic Disorders trials

The registry lists 17 Psychotic Disorders studies with Mclean Hospital as lead sponsor. 6 are open to participants now and 9 have results posted.

Phase 1 1Phase 2 3Phase 4 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early PsychosisNot yet recruitingNCT07503093Not applicable
• Open Label Extension Study of NCT06221852Enrolling by invitationNCT06558201Not applicable
• Ketogenic and Nutritional Interventions for First Episode Bipolar DisorderRecruitingNCT06221852Not applicable
• Cerebellar Modulation of Cognition in PsychosisRecruitingNCT06107764Not applicable
• Enhanced Coordinated Specialty Care for Early PsychosisRecruitingNCT06071858Not applicable
• Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in SchizophreniaRecruitingNCT05343598Not applicable
• Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot StudyCompletedNCT05380583Not applicableResults posted
• Families With Substance Use and Psychosis: A Pilot StudyCompletedNCT04284813Not applicableResults posted
• Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic DisordersCompletedNCT03943537Phase 2Results posted
• Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) StudyCompletedNCT02642029Not applicableResults posted
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI PatientsCompletedNCT02188121Phase 4Results posted
• Neurobiology of a Mutation in Glycine Metabolism in Psychotic DisordersCompletedNCT01720316Phase 2Results posted
• Acute Glycine Pharmacodynamic StudyCompletedNCT01610011Not applicableResults posted
• Treatment to Enhance Cognition in Bipolar DisorderCompletedNCT01470781Not applicableResults posted
• Effects of Pentazocine Versus Lorazepam on Manic SymptomsCompletedNCT00431184Phase 2Results posted
• Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode PsychosisCompletedNCT01688765
• Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-EffectsCompletedNCT00567034Phase 1